FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • FAQ
  • How to use FRC

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Q2 on Target: Positive Outlook Amid High Oil Prices… (CTEK, Aug 2023) | FRC
Home🔹Latest Reports🔹CynergisTek, Inc.🔹Q2 on Target: Positive Outlook Amid High Oil Prices and Sector Consolidation
CynergisTek, Inc.

Q2 on Target: Positive Outlook Amid High Oil Prices and Sector Consolidation

ByFRC TeamAugust 10, 2023

Disclosure: CynergisTek, Inc. has paid FRC a fee for research coverage and distribution of reports. See last page for other important disclosures, rating, and risk definitions.

Rating and Key Data

Locked
MetricsValue
Free with an FRC account

Unlock the full CTEK analysis — free account

The rating, fair value and the complete CynergisTek, Inc. profile — not just a price:
ValuationFair value, FRC rating & peer comparablesFundamentalsFinancials, ratios, earnings & dividendsWho's buyingInstitutions, insiders & Congress tradesContextLive quote, chart, news & FRC reports
No credit card. Already have an account?
Preview the CTEK profile

Rating and Key Data

Locked
MetricsValue
Free with an FRC account

Unlock the full CTEK analysis — free account

The rating, fair value and the complete CynergisTek, Inc. profile — not just a price:
ValuationFair value, FRC rating & peer comparablesFundamentalsFinancials, ratios, earnings & dividendsWho's buyingInstitutions, insiders & Congress tradesContextLive quote, chart, news & FRC reports
No credit card. Already have an account?
Preview the CTEK profile

Related Content

More Research Reports

Global Education Communities Corp.

Rental Strength Drives EPS Beat; Structural Housing Tailwinds

April 19, 2026
Rental Strength Drives EPS Beat; Structural Housing Tailwinds
Zepp Health Corporation

Strong Execution, Deep Discount: Market Missing the Turnaround

April 16, 2026
Strong Execution, Deep Discount: Market Missing the Turnaround
Denarius Metals Corp.

Nears a Transformative Milestone: Approaching Commercial Gold Production

April 7, 2026
Nears a Transformative Milestone: Approaching Commercial Gold Production
Bayhorse Silver Inc.

Near-Term Silver Production with Potential for Other Critical Minerals in the U.S. - Resuming Coverage

April 2, 2026
Near-Term Silver Production with Potential for Other Critical Minerals in the U.S. - Resuming Coverage
Market Intel Weekly

Data Backs Our Rate Cut Predictions / Time to Revisit Lithium Stocks

June 3, 2024
Thumbnail for Data Backs Our Rate Cut Predictions / Time to Revisit Lithium Stocks
Market Intel Weekly

Bright Prospects for the US$ / Bitcoin Optimism / Our Top Picks Continue to Outperform

May 27, 2024
Thumbnail for Bright Prospects for the US$ / Bitcoin Optimism / Our Top Picks Continue to Outperform
Market Intel Weekly

Our Analysts Predicted This Epic Climb!

May 21, 2024
Thumbnail for Our Analysts Predicted This Epic Climb!
Market Intel Weekly

US$ Outlook / A Limited-Time Opportunity in the Junior Gold Space

May 13, 2024
Thumbnail for US$ Outlook / A Limited-Time Opportunity in the Junior Gold Space

From the FRC Archive

  • Cost-Effective/ESG Friendly Solutions for The Energy Sector – Initiating CoverageCleantek Industries Inc. · 2022
  • Acquiring a Health-Tech Company with DHL as a Client – Initiating CoverageEUDA Health Holdings Limited · 2022
  • Successfully Diversifying to B.C.Builders Capital Mortgage Corp. · 2022
  • Awaiting Results of Phase II Trials of a Potential Therapy for Cardiovascular Diseases – Initiating CoverageHemostemix Inc. · 2022